$BLUE News Article - bluebird bio Receives Positive Opinion from CHMP for ZYNTEGLO(TM) (autologous CD34+ cells encoding ?A-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent ?-Thalassemia (TDT) Who Do Not Have ?0/?0 Genotype
https://marketwirenews.com/news-releases/blue...12340.html